Dottikon ES Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dottikon ES Holding AG with three other
pharmaceutical manufacturers in Europe:
Allergy Therapeutics PLC
of the United Kingdom
sales of £68.35 million [US$88.30 million]
of which 100%
(206.70 million Euro [US$233.82 million]
Eco Animal Health Group Plc
based in the United Kingdom
(£67.20 million [US$86.82 million]
of which 100%
was Animal Health Product).
During the year ended March of 2018, sales at
Dottikon ES Holding AG were 158.23 million Swiss Francs (US$157.60 million).
increase of 4.3%
versus 2017, when the company's sales were 151.75 million Swiss Francs.
This was the fifth consecutive year of sales increases at Dottikon ES Holding AG
(and since 2013, sales have increased a total of 88%).
Sales of Pharma Products saw an increase
6.5% in 2018, from
135.17 million Swiss Francs to 143.94 million Swiss Francs.
Not all segments of Dottikon ES Holding AG experienced an increase in sales in 2018:
sales of Recycling and Waste fell 43.5% to 2.15 million Swiss Francs.
(However, this segment's sales were only a very small portion of the company's overall sales).
Dottikon ES Holding AG also experienced decreases in sales in
Fine Chemicals (down 5.0% to 12.14 million Swiss Francs)